Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

Novo Nordisk · Phase 3 · Completed · Enrollment 846

NCT01272232

EudraCT 2008-002199-88

Y axis: Change in body weight from baseline, %

50-504812162024364860Lira 3.0 mg, week 56, 2.3%Lira 3.0 mgLira 1.8 mg, week 56, 2%Lira 1.8 mgPlacebo, week 56, -0.1%Placebo

X axis: Weeks since randomization

Cited trial source. Only weeks the source states.

  • Lira 3.0 mg: week 56 2.3%
  • Lira 1.8 mg: week 56 2%
  • Placebo: week 56 -0.1%

One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.